| Income Statement |
| Total Revenue | 153.60M |
|
| Revenues (USD) | 153.60M |
| Cost of Revenue | 34.98M |
| Gross Profit | 118.63M |
| Operating Expenses | 108.96M |
| Research and Development Expense | 26.40M |
| Selling, General and Administrative Expense | 82.56M |
| Operating Income | 9.66M |
| Interest Expense | 1.32M |
| Income Tax Expense | 471.00K |
| Net Income | 8.96M |
| Net Income Common Stock | 8.96M |
| Net Income Common Stock (USD) | 8.96M |
| Consolidated Income | 8.96M |
| Earnings per Basic Share | 0.18 |
| Earnings per Basic Share (USD) | 0.18 |
| Earnings per Diluted Share | 0.18 |
| Earning Before Interest & Taxes (EBIT) | 10.74M |
| Earning Before Interest & Taxes (USD) | 10.74M |
| Weighted Average Shares | 48.67M |
| Weighted Average Shares Diluted | 48.87M |
| Balance Sheet |
| Cash and Equivalents | 167.79M |
| Cash and Equivalents (USD) | 167.79M |
| Trade and Non-Trade Receivables | 79.98M |
| Current Assets | 345.53M |
| Property, Plant & Equipment Net | 48.49M |
| Total Assets | 676.64M |
| Total Debt | 71.05M |
| Current Liabilities | 81.92M |
| Debt Non-Current | 71.05M |
| Total Liabilities | 160.21M |
| Accumulated Retained Earnings (Deficit) | -404.14M |
| Accumulated Other Comprehensive Income | 101.00K |
| Shareholders Equity | 516.43M |
| Shareholders Equity (USD) | 516.43M |
| Assets Non-Current | 331.11M |
| Total Debt (USD) | 71.05M |
| Goodwill and Intangible Assets | 278.04M |
| Inventory | 83.93M |
| Liabilities Non-Current | 78.29M |
| Trade and Non-Trade Payables | 35.85M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.31M |
| Net Cash Flow from Financing | 3.26M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 21.62M |
| Capital Expenditure | -3.77M |
| Issuance (Purchase) of Equity Shares | 3.60M |
| Issuance (Repayment) of Debt Securities | -336.00K |
| Net Cash Flow from Investing | -3.77M |
| Net Cash Flow from Operations | 22.19M |
| Effect of Exchange Rate Changes on Cash | -67.00K |
| Share Based Compensation | 12.31M |